These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6439109)

  • 21. [Use of prodigiozan and zymosan in treating children with viral hepatitis A].
    Lebenzon SS; Maianskiĭ DN; Gavrilova NI; Kutina SN
    Pediatriia; 1988; (6):27-30. PubMed ID: 3186403
    [No Abstract]   [Full Text] [Related]  

  • 22. [Parenteral use of a therapeutic vaccine in acute dysentery].
    Ermakova ZF
    Sov Med; 1979 May; (5):83-6. PubMed ID: 377515
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of dysentery in children with a combination of monomycin and Eleutherococcus].
    Vereshchagin IA
    Antibiotiki; 1978 Jul; 23(7):633-6. PubMed ID: 354512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Humoral and cellular immunity in patients with acute dysentery].
    Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN
    Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of bacillary dysentery using a live anti-dysentery vaccine in a group of neuropsychopathic children].
    Meitert T; Istrati G; Sulea IT; Baron E; Andronescu C; Gogulescu L; Templea C; Ianopol L; Galan L; Fleşeriu M; Onciu C; Bogos L; Lupovici R; Boghiţoiu G; Ohmt E; Popescu G; Mihailiuc I; Maftei S; Tapu T; Zebreniuc D
    Arch Roum Pathol Exp Microbiol; 1973 Mar; 32(1):35-44. PubMed ID: 4585403
    [No Abstract]   [Full Text] [Related]  

  • 26. [Importance of cellular and humoral immunity factors in dysentery in children].
    Tartakovskaia RA
    Vopr Okhr Materin Det; 1976 Nov; 21(11):43-5. PubMed ID: 795153
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of prodigiozan and pyrimidine derivatives on the effectiveness of the antibiotic therapy of experimental infections].
    Bakirov AB
    Antibiotiki; 1979 Sep; 24(9):673-8. PubMed ID: 384893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative assessment of pathogenic agents in the combined treatment of respiratory organ tuberculosis].
    Karapetian ET; Markova EF; Gasparian AA; Apresian EA; Saakian AL
    Probl Tuberk; 1982 Mar; (3):40-4. PubMed ID: 7088922
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinico-epidemiologic significance of episomal resistance to antibiotics in shigellae].
    Astapov AA; Amvrosiev IuA; Tsynkalovskii IB
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):71-5. PubMed ID: 4616591
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prodigiozan in the therapy of destructive pulmonary tuberculosis].
    Kornilova ZKh; Svitneva AS
    Probl Tuberk; 1980 Jan; (1):30-2. PubMed ID: 7367422
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interferonogenic properties of prodigiozan and its effectiveness in treating acute respiratory diseases in children].
    Povolotskiĭ IaL; Andrushchuk AA; Korzhenevskiĭ AF; Krivokhatskaia LD
    Antibiotiki; 1980 Jul; 25(7):531-4. PubMed ID: 6157358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the effectiveness of prodigiozan in acute respiratory viral infections in young infants].
    Raĭnite-Audinene AB; Uspenskiĭ IuS; Priĭmiagi LS; Kremerman IB; Voloshina LZ
    Pediatriia; 1979 Dec; (12):44-6. PubMed ID: 523271
    [No Abstract]   [Full Text] [Related]  

  • 33. [Characteristics of serum immunoglobulins in Sonne dysentery in children].
    Nesterina LF; Vasil'eva IG; Bakulina TB
    Vopr Okhr Materin Det; 1975 May; 20(5):88. PubMed ID: 1096467
    [No Abstract]   [Full Text] [Related]  

  • 34. [Relation of dysentery drug therapy to the development of antibiotic resistance in Shigella].
    Kheĭlik AG; Man'kovskiĭ AV
    Antibiotiki; 1981 Aug; 26(8):606-7. PubMed ID: 7027914
    [No Abstract]   [Full Text] [Related]  

  • 35. [Various approaches to treatment of dysentery in children].
    Iushkevich SB; Pozniak SB; Pivovarchik RA
    Antibiot Khimioter; 1993; 38(4-5):40-2. PubMed ID: 8031196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of prodigiozan in the combined therapy of infectious diseases (a review of the literature)].
    Frolov VM; Rychnev VE
    Vrach Delo; 1986 Feb; (2):111-4. PubMed ID: 3518241
    [No Abstract]   [Full Text] [Related]  

  • 37. Prophylaxis of bacillary dysentery by liver vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in IS County.
    Oană C; Buzdugan T; Constantiniu S; Cismaru M; Alexandru D; Dunea C; Funiac A; Radu M; Grumăzescu C; Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):331-5. PubMed ID: 6400307
    [No Abstract]   [Full Text] [Related]  

  • 38. [Levels of erythrocyte cholinesterase in children treated with monomycin and neomycin].
    Vereshchagin IA
    Antibiotiki; 1972 Aug; 17(8):757-9. PubMed ID: 4564364
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduction of morbidity due to bacillary dysentery by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in BH County.
    Pop C; Cernea L; Ciortea A; Ianossy L; Kallay T; Lugoş A; Meitert T; Ciudin L; Pencu E
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):351-6. PubMed ID: 6400310
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of lysozyme and prodigiozan in the treatment of suppurative infections in diabetics].
    Nuzov BG
    Vestn Khir Im I I Grek; 1984 Apr; 132(4):62-5. PubMed ID: 6730182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.